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Background: Insulin resistance (IR) plays a key role in the pathogenesis of type 2
diabetes (T2D). In neurologically impaired (NI) children unfavorable cardio-metabolic risk
profile with high prevalence of IR has been reported. We evaluated the prevalence of T2D
in NI children and adolescents, in order to define if a dedicated glucose monitoring may
be recommended in these subjects.
Methods: We retrospectively evaluated 63 patients (11.4 ± 4.0 years) with severe
disabilities. Auxological parameters were recorded. Metabolic blood assays included
fasting blood glucose (FBG), fasting insulin, triglycerides (TG). IR was detected with
the homeostasis model assessment for insulin resistance (HOMA-IR > 97.5th percentile
for age and sex) and triglyceride-glucose index (TyG index > 7.88). Elevated FBG was
defined with values >100 mg/dl. T2D was defined according to American Diabetes
Association criteria.
Results: Impaired insulin sensitivity, pathological TyG index and elevated FBG were
observed, respectively, in 41.3, 63.5, and 11.1% patients. T2D was diagnosed in 3.2%
asymptomatic patients. The prevalence of diabetes was higher in pre-pubertal compared
to pubertal subjects (p = 0.03).
Conclusions: T2D in NI children and adolescents without obesity could represent a new
emerging entity. IR and/or surrogate markers of IR index may be useful for the primary
screening of this at-risk disabled population so as to prevent diabetes.
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INTRODUCTION
Youth type 2 diabetes (T2D) is increasing, linked with obesity and declining physical activity in
high-risk population (1). In the United States, the prevalence of T2D in 2009 among adolescents
aged 10 through 19 years was 0.46 per 1,000 or 0.046%, with highest prevalence in American
Indians, followed by black, Hispanic, and Asian Pacific Islander youths, with lowest prevalence
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in white ones (1–3). Studies in Europe indicate that T2D remains
rare in largely white populations (4–8).
Insulin resistance (IR) plays a key role in the pathogenesis of
T2D (1). Previously, we described that neurologically impaired
(NI) children showed an unfavorable cardio-metabolic risk
profile with a high prevalence of IR which was not related to
BMI (9–11).
In this brief report, we evaluated the prevalence of T2D in NI
children and adolescents without obesity, in order to describe if
a dedicated glucose profile monitoring may be recommended in
this “fragile” population.
PATIENTS AND METHODS
Patients
We retrospectively evaluated 63 caucasian patients (35
males/28 females, mean age 11.4 ± 4.0 years, range 1.9–
19.1 yr) with severe disabilities (cerebral palsy 34.9%, epileptic
encephalopathy 28.6%, severe psychomotor developmental delay
in dysmorphic syndromes 36.5%). All patients presented with
neuromotor damage that could alter their ability to self-feed and
were bedridden.
All subjects had been previously scheduled for surgical
treatment (gastrostomy/jejunostomy tube positioning, anti-
reflux surgical treatment) and/or management of nutritional
support devices.
Enteral feeding was adopted in 58/63 participants (bolus
82.7%, continuous pump feeding 17.3%) and oral feeding in 5/63
subjects (8%). Anticonvulsive drugs (at least two of the following:
phenobarbital, valproic acid, phentoyn, lamotrigine, topiramate,
carbamazepine, and clonazepam) were reported in 56/63 (88.8%)
of the whole sample; other therapies were recorded in 5 patients
(in 3 anti-hypertensive drugs, in 1 growth hormone therapy, in
1 L-thyroxine).
In all subjects physical activity was conducted for
<60 min/week.
The study was performed according to the Declaration of
Helsinki and with the approval of the Institutional Review Board.
Parents and/or legal guardian, after receiving information about
the study, gave their written consent.
Methods
Clinical and Anthropometric Parameters
Physical examination of the subjects included anthropometric
parameters as well as pubertal stage evaluation according
to Marshall and Tanner (12, 13) (pre-pubertal characteristics
corresponding to Tanner stage 1).
Weight, height, waist circumference (WC) were measured as
previously reported (11) and consequently BMI and waist to
height ratio (WHtR) were calculated.
Metabolic Parameters
Metabolic blood assays included fasting blood glucose (FBG),
insulin, triglycerides (TG). Insulin resistance was calculated
with the homeostasis model assessment for insulin resistance
(HOMA-IR) (14). Triglyceride-glucose index (TyG index)
was also evaluated using the formula (ln[fasting triglycerides
(mg/dl)× fasting plasma glucose (mg/dl)/2]) (15), as a surrogate
marker of IR and predictor of diabetes.
Elevated FBG was defined with values exceeding 100 mg/dl
and impaired insulin sensitivity (ISI) with a HOMA-IR exceeding
the 97.5th percentile for age and sex (16).
According to Vieira Ribeiro, TyG index was considered
pathological with a cut-off exceeding 7.88.
T2D was defined as FBG ≥ 126 mg/dL and/or 2 h plasma
glucose (PG) ≥ 200 mg/dL and/or random PG ≥ 200 mg/dL
(in patients with continuous pump feeding only random PG ≥
200 mg/dL was considered) plus symptoms of diabetes (given
the feeding difficulties, of these children, only polyurea was
considered) and HbA1c ≥ 6.5% (17).
In diabetic patients the presence of islet autoimmunity
[glutamic acid decarboxylase (GAD), islet antigen type 2 (IA2),
anti-insulin (IAA), and zinc transporter 8 (ZnT8) autoantibodies]
were excluded.
The waist to height ratio (WHtR) was then calculated with the
standard formula and a cut-off of 0.5 was used to differentiate low
from high WHtR (18).
Treatment following diabetes diagnosis was recorded.
Statistical Analysis
The Shapiro-Wilk test was used to assess the normal distribution
of quantitative variables. When quantitative variables were
normally distributed, the results were expressed as the
mean value and standard deviation (SD), otherwise median
and interquartile range (IQR; 25th−75th percentile) were
reported. Qualitative variables were summarized as counts and
percentages. Associations between sex or pubertal stage and
continuous variables were tried through t-test or non parametric
Mann-Whitney test for the former and oneway analysis of
variance followed by Scheffe corrected 2 × 2 post hoc test for
the latter; chi square test was used for qualitative variables. A
p < 0.05 was considered statistically significant. Multivariate
(including sex and pubertal stage as independent variables)
linear or logistic regression models were fitted.
RESULTS
In Table 1, the clinical features and metabolic parameters of the
patients are reported.
The average HOMA-IR was 3.5 ± 0.6, with higher levels
in pubertal compared to pre-pubertal patients (p = 0.03) and
without significant difference between sex (p = 0.3). Insulin
resistance was detected in 26/63 (41.3%) subjects, with a similar
prevalence in males and females (p = 0.7) and in pre-pubertal
and pubertal subjects (p= 0.1).
The mean values of TyG index observed in the sample was
8.1± 0.75, which is higher in pubertal compared to pre-pubertal
patients (p = 0.03) and did not differ between genders (p =
0.6). Pathological TyG index was noted in 40/63 patients (63.5%),
without significant difference according to sex (p = 0.3) and
pubertal status (p= 0.6).
No significant correlation between HOMA-IR and TyG was
found (r = 0.17 p= 0.20).
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Pathological FBG was detected in 7/63 children (11.1%),
without difference between sex (p = 0.3 and pubertal
stage (p= 0.09).
T2D was diagnosed in 2/63 patients (3.2%; 1 male and
female with dysmorphic syndromes in which inborn errors of
metabolism and mitochondrial disease were excluded) at the age
of 4 and 8 years, respectively. Both patients were asymptomatic
and diabetes was incidentally detected during a routine checkup.
TABLE 1 | Clinical and metabolic feature of the patients.
Sex (M/F) 35/28
Age (years) 11.4 ± 4.0
Pubertal stages
0 (Tanner stage 1)
1 (Tanner stage 2–3)
2 (Tanner stage 4–5)
15
20
28
BMI (kg/m2) 12.01 ± 5.91
BMI-SDS (kg/m2) −2.26 ± 2.86
Waist circumference (cm) 67.9 ± 15.2
Waist-to-height ratio 0.3 ± 0.2
Fasting blood glucose (mg/dl) 88.3 ± 9.1
Fasting insulin (micro IU/ml) 19.9 ± 23.9
Triglycerides (mg/dl) 108.1 ± 8.5
HOMA-IR 3.5 ± 0.6
Triglyceride-glucose index 8.1 ± 0.75
Clinical and biochemical data and treatment following diagnosis
was reported inTable 2. In both patients, IR or surrogate markers
of IR were detected.
The prevalence of diabetes was higher in pre-pubertal
compared to pubertal subjects (p = 0.03), similarly in males and
females (p= 0.8).
No association between metabolic alterations and type
of nutritional support (p = 0.1) or drug exposure was
noted (p= 0.9).
DISCUSSION
Individuals with neurological impairment are at increased risk
for frailty and chronic disease due to factors experienced
throughout lifespan, such as excessive sedentary behaviors and
malnutrition (19). Unfavorable cardio-metabolic profile and
high allostatic load have been previously reported in early
childhood (9–11). However, little is known about diabetes in
disabled population.
This is the first study to report a certain prevalence of diabetes
mellitus (3.2%) in the NI pediatric population. We demonstrated
that ISI and pathological surrogate markers of insulin resistance
index are common in children and adolescents with NI and
showed that a high prevalence of diabetes is also relevant in
pre-pubertal subjects.
Glucose homeostasis is maintained by a delicate coupling of
insulin secretion, from pancreatic β-cells, with insulin sensitivity
TABLE 2 | Clinical and metabolic feature of the 2 patients with diabetes.
Patient 1 Patient 2
Sex Male Female
Age 4 8
Family history for diabetes Absent Absent
Neurological disorders Lissencephaly with cerebellar dysplasia Corpo callosum hypoplasia, delayed
myelination, simplified gyration
Concomitant pathologies None Biatrial enlargement
Treatment Anticonvulsive drugs Growth hormone
Ketoacidosis at diagnosis Absent Absent
Symptoms recorded at diagnosis None None
Glycemia at the diagnosis 355 490
HBA1c 7.8 9.5
Waist circumference (cm) 50 (<50◦ centile) 48 (<50◦ centile)
Waist-to-height ratio 0.45 0.44
BMI (kg/m2) 14.8 12.6
BMI z-score 1.5 −1.6
HOMA-IR 10.6 1.6
Triglyceride-glucose index 9.58 9.83
c-peptide Not available 1.6
Autoimmune markers
Islet cell autoantibodies
Autoantibodies to GAD (GAD65)
Autoantibodies to the tyrosine phosphatases IA-2
Autoantibodies to zinc transporter 8 (ZnT8)
Not available
Negative
Negative
Not available
Negative
Negative
Negative
Negative
HLA risk haplotypes Not available Absent
Therapy following diagnosis Metformin Insulin
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(skeletal muscle, adipose tissue, and hepatic) (1). When insulin
sensitivity declines, insulin secretion must increase to maintain
glucose tolerance and finally when β-cells are no longer able
to secrete sufficient insulin to overcome insulin resistance, IGT
ensues progressing to T2D (1).
Overweight and obesity are major contributors to the
development of T2D, which represents the 1% of diabetes subtype
in the italian pediatric population (20). There are few data
on T2D prevalence in children without obesity and in this
population diabetes is described as a major complication of post-
transplant immunosuppressive therapy for kidney (21), liver
(22), or hematological diseases (23) with a broad range (1.8–13%)
depending of the treatment process (21–23).
We showed that the development of T2D and IR may
also be observed in NI patients without obesity, not on
immunosuppressive drugs, with no difference between sex. As
previously reported, IR in these disabled patients was not
correlated to BMI nor to energy intake (11). Negative regulation
of insulin signaling could be viewed as a physiologic “adaptive
mechanism for human survival” that is activated whenever the
organism needs to switch from an anabolic to a catabolic or
“insulin resistance” state, such as undernutrition, and to mobilize
energy to support vital metabolic processes (9–11, 24–26). The
restricted physical activity (27) may also play a crucial role on
insulin resistance; it causes a rapid loss of lean mass, which is
associated with a decline in basal metabolic rate and increased
whole body and regional adiposity leading to insulin signaling
interference (10). Additionally, chronic stress also tends to alter
the anabolic/catabolic hormonal balance and may be involved
in increased cortisol levels and insulin resistance (28). Finally,
long-term therapy, such as anticonvulsive drugs and hormonal
therapy may be associated with several metabolic abnormalities
and their effects on insulin resistance and diabetes should be
considered (9–11).
Glucose and lipidmetabolism are linked to each other inmany
ways (29). Hypertriglyceridemia is the characteristic dyslipidemia
in subjects with IR (29). Although no definitive explanation is
still available for the correlation between hypertriglyceridemia
and IR, it has been reported that elevated TG levels interfere
with glucose metabolism in muscles, a finding consistent with
the hypothesis that TG elevation in serum and tissue is related to
decreased insulin sensitivity (29–31). Markers of insulin action
based on lipids may help identify subjects with IR (32–36). The
TyG index which is a surrogate marker of IR, is known to be
associated with metabolic parameters and CVD and it had some
prognostic value to predict T2D also in normoglycemic patients
and normal-weight patients (32–34, 36). In our report a higher
percentage of patients without obesity, with significant difference
between sexes, showed pathological TyG index, in accordance
with the presence of IR. Considering the unfavorable cardio-
metabolic risk profile of this disabled population (9–11), this
marker may be useful for predicting T2D in clinical practice and
may provide a feasible alternative to the expensive and invasive
gold standard test for IR.
We observed a lack of correlation between HOMA-
IR and TyG index; this result could be due to the fact
that the HOMA-IR does not change at the same time
as the TyG index. Youth T2D is associated with insulin
resistance, together with progressive deterioration in cell
function and relative insulin deficiency in the absence of
diabetes-related immune markers (1). Therefore HOMA-IR
may not be altered when insulin reserves are running out.
Further longitudinal studies are mandatory to clarify the
natural history of ISI and β-cell Function in neurologically
impaired youth.
We must acknowledge that the study has some limitations.
The sample size was too small to define a prevalence of
diabetes mellitus, moreover due to the difficulties in enrolling
and studying neuro-cognitively disabled children, this metabolic
aspect is interesting to consider for disabled young patients
monitoring. The gold standard method for the determination
of insulin sensitivity is the hyperinsulinemic euglycemic glucose
clamp, moreover it is impractical in these young disabled
people so we used HOMA-IR and TyG index because. Finally,
several factors, such as inadequate nutritional status, low physical
activity level, polypharmacotherapy, may synergically affect
metabolic profile, however the effects of any single event was
not measured. Additionally, a genetic component of diabetes is
not excluded.
In conclusion, T2D in NI children and adolescents
could represent a new emerging entity in subjects without
obesity. Insulin resistance and/or surrogate marker of
insulin resistance index may be useful for the early
screening of these at-risk disabled populations in order to
prevent diabetes.
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